ID

31918

Descripción

Study ID: 105-040 Clinical Study ID: 105-040 Study Title: A Multicenter, Double-Blind, Placebo-Controlled, Parallel-Design Evaluation of LAMICTAL for Add-on Treatment of Partial Seizures in Pediatric Patients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: lamotrigine Trade Name: lamictal Study Indication: Epilepsy, Partial

Palabras clave

Versiones (3)
  1. 30/9/18 30/9/18 -
  2. 8/10/18 8/10/18 -
  3. 8/10/18 8/10/18 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

8 de octubre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

Sin comentarios

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Evaluation of LAMICTAL for Add-on Treatment of Partial Seizures in Pediatric Patients 105-040

Inglés

Investigator Comment Log, Patient Discharge Notification Postcard, Last Dose of Study Drug Record, End of Study Record, Status of Randomization Code/ Investigator's Statement and Laboratory Comments

1 formularios  
Administrative
Descripción

Administrative

Alias
UMLS CUI-1
C1320722
Site number
Descripción

Study Site; Numbers

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2825164
UMLS CUI [1,2]
C0237753
Patient's initials
Descripción

Person Initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Patient's trial number
Descripción

Clinical Trial Subject Unique Identifier

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Investigator Comment Log
Descripción

Investigator Comment Log

Alias
UMLS CUI-1
C0008961
UMLS CUI-2
C0947611
Comment Date
Descripción

Comment; Date in time

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0947611
UMLS CUI [1,2]
C0011008
Page number
Descripción

Page (document); Numbers

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1704732
UMLS CUI [1,2]
C0237753
Comments
Descripción

Comment

Tipo de datos

text

Alias
UMLS CUI [1]
C0947611
Patient Discharge Notification Postcard
Descripción

Patient Discharge Notification Postcard

Alias
UMLS CUI-1
C0030685
UMLS CUI-2
C0422202
Project number
Descripción

Project; Identification number

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1709701
UMLS CUI [1,2]
C1300638
Protocol number
Descripción

Study Protocol; Numbers

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C2348563
UMLS CUI [1,2]
C0237753
Site number
Descripción

Study Site; Numbers

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2825164
UMLS CUI [1,2]
C0237753
Date discharged
Descripción

Discharge date

Tipo de datos

date

Alias
UMLS CUI [1]
C2361123
Patient's initials
Descripción

Person Initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Patient's trial number
Descripción

Clinical Trial Subject Unique Identifier

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Last dose of study drug record
Descripción

Last dose of study drug record

Alias
UMLS CUI-1
C3854006
UMLS CUI-2
C0178602
UMLS CUI-3
C0034869
UMLS CUI-4
C1517741
Was study drug stopped permanently before completion of all 18 weeks of treatment and taper?
Descripción

Experimental drug; Discontinuation (procedure) | Completion Status; Therapeutic procedure

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0457454
UMLS CUI [2,1]
C0805732
UMLS CUI [2,2]
C0087111
If study drug stopped, check the primary reason drug was stopped
Descripción

Experimental drug; Discontinuation (procedure); Indication of (contextual qualifier)

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0457454
UMLS CUI [1,3]
C0392360
Date of last dose
Descripción

Date last dose

Tipo de datos

date

Alias
UMLS CUI [1]
C1762893
End of study record
Descripción

End of study record

Alias
UMLS CUI-1
C0008976
UMLS CUI-2
C0444496
Did the patient complete the Screen, Baseline, Treatment Phases and Taper?
Descripción

Baseline; Complete | Screening procedure; Complete | treatment phases; Complete | Tapering - action; Complete

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1442488
UMLS CUI [1,2]
C0205197
UMLS CUI [2,1]
C0220908
UMLS CUI [2,2]
C0205197
UMLS CUI [3,1]
C0815181
UMLS CUI [3,2]
C0205197
UMLS CUI [4,1]
C0441640
UMLS CUI [4,2]
C0205197
If patient did not complete Screen, Baseline, Treatment Phases and Taper, check primary reason.
Descripción

Baseline; Screening procedure; treatment phases; Tapering - action; Complete; Reason and justification

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1442488
UMLS CUI [1,2]
C0205197
UMLS CUI [1,3]
C0566251
UMLS CUI [2,1]
C0220908
UMLS CUI [2,2]
C0205197
UMLS CUI [2,3]
C0566251
UMLS CUI [3,1]
C0815181
UMLS CUI [3,2]
C0205197
UMLS CUI [3,3]
C0566251
UMLS CUI [4,1]
C0441640
UMLS CUI [4,2]
C0205197
UMLS CUI [4,3]
C0566251
Date patient discharged from the study
Descripción

No further protocol specified treatments or evaluations are planned

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2361123
UMLS CUI [1,2]
C2603343
Did the patient die anytime during the study (Baseline Day 1 through Taper and Folllow-Up Phases?)
Descripción

Cessation of life; Clinical Trials; During

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011065
UMLS CUI [1,2]
C0008976
UMLS CUI [1,3]
C0347984
UMLS CUI [2]
C1442488
UMLS CUI [3]
C0441640
UMLS CUI [4]
C1522577
If patient died, onset date of the event wich led to death
Descripción

Death Related to Adverse Event; Date of onset

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1705232
UMLS CUI [1,2]
C0574845
Date of death
Descripción

Date of death

Tipo de datos

date

Alias
UMLS CUI [1]
C1148348
Characterize the cause of death
Descripción

Cause of Death

Tipo de datos

integer

Alias
UMLS CUI [1]
C0007465
If other cause of death, specify.
Descripción

Cause of Death; Other; Specification

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0007465
UMLS CUI [1,2]
C0205394
UMLS CUI [1,3]
C2348235
Check attribution of death to study medication
Descripción

Cessation of life; Experimental drug; attribution

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0011065
UMLS CUI [1,2]
C0304229
UMLS CUI [1,3]
C0596130
Was an autopsy performed?
Descripción

Autopsy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004398
Status of randomization code/ Investigator's statement
Descripción

Status of randomization code/ Investigator's statement

Alias
UMLS CUI-1
C0034656
UMLS CUI-2
C0805701
UMLS CUI-3
C0449438
UMLS CUI-4
C0008961
UMLS CUI-5
C1710187
Was the blind on the randomization code for this patient broken?
Descripción

Randomization; Code; Blinded Clinical Study Unit

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0805701
UMLS CUI [1,3]
C2347038
UMLS CUI [1,4]
C3846158
Date of blind was broken
Descripción

Date in time; Blinded Clinical Study

Tipo de datos

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2347038
UMLS CUI [1,3]
C3846158
Reason for breaking blind
Descripción

Date in time; Blinded Clinical Study

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C2347038
UMLS CUI [1,3]
C3846158
Investigator's statement
Descripción

Investigator's statement

Alias
UMLS CUI-1
C0008961
UMLS CUI-2
C1710187
Investigator's Signature
Descripción

Investigator Signature

Tipo de datos

text

Alias
UMLS CUI [1]
C2346576
Date of Signature
Descripción

Investigator Signature; Date in time

Tipo de datos

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Investigator's name
Descripción

Investigator Name

Tipo de datos

text

Alias
UMLS CUI [1]
C2826892
Laboratory Comments - Unscheduled Laboratory Assessment
Descripción

Laboratory Comments - Unscheduled Laboratory Assessment

Alias
UMLS CUI-1
C0022877
UMLS CUI-2
C0947611
UMLS CUI-3
C0220825
UMLS CUI-4
C0022877
UMLS CUI-5
C3854240
Do you consider any of the laboratory values at this clinic visit to be of potential OR actual clinical significance AND unexpected in this patient population?
Descripción

Laboratory Results; Clinical Significance; Unexpected

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1254595
UMLS CUI [1,2]
C2826293
UMLS CUI [1,3]
C4055646
Laboratory results that are of potential or actual clinical significance and unexpected
Descripción

Laboratory results that are of potential or actual clinical significance and unexpected

Alias
UMLS CUI-1
C1254595
UMLS CUI-2
C2826293
UMLS CUI-3
C4055646
Laboratory parameter
Descripción

Laboratory; Parameter Value

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0022877
UMLS CUI [1,2]
C0549193
Comment (Laboratory parameter)
Descripción

Comment | Laboratory; Parameter Value

Tipo de datos

text

Alias
UMLS CUI [1]
C0947611
UMLS CUI [2,1]
C0022877
UMLS CUI [2,2]
C0549193
Volver a la parte superior de la página

Similar models

Investigator Comment Log, Patient Discharge Notification Postcard, Last Dose of Study Drug Record, End of Study Record, Status of Randomization Code/ Investigator's Statement and Laboratory Comments

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative
C1320722 (UMLS CUI-1)
Study Site; Numbers
Item
Site number
text
C2825164 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Person Initials
Item
Patient's initials
text
C2986440 (UMLS CUI [1])
Clinical Trial Subject Unique Identifier
Item
Patient's trial number
text
C2348585 (UMLS CUI [1])
Item Group
Investigator Comment Log
C0008961 (UMLS CUI-1)
C0947611 (UMLS CUI-2)
Comment; Date in time
Item
Comment Date
date
C0947611 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Page (document); Numbers
Item
Page number
integer
C1704732 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Comment
Item
Comments
text
C0947611 (UMLS CUI [1])
Item Group
Patient Discharge Notification Postcard
C0030685 (UMLS CUI-1)
C0422202 (UMLS CUI-2)
Project; Identification number
Item
Project number
integer
C1709701 (UMLS CUI [1,1])
C1300638 (UMLS CUI [1,2])
Study Protocol; Numbers
Item
Protocol number
integer
C2348563 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Study Site; Numbers
Item
Site number
text
C2825164 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Discharge date
Item
Date discharged
date
C2361123 (UMLS CUI [1])
Person Initials
Item
Patient's initials
text
C2986440 (UMLS CUI [1])
Clinical Trial Subject Unique Identifier
Item
Patient's trial number
text
C2348585 (UMLS CUI [1])
Item Group
Last dose of study drug record
C3854006 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
C0034869 (UMLS CUI-3)
C1517741 (UMLS CUI-4)
Experimental drug; Discontinuation (procedure) | Completion Status; Therapeutic procedure
Item
Was study drug stopped permanently before completion of all 18 weeks of treatment and taper?
boolean
C0304229 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C0805732 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
Item
If study drug stopped, check the primary reason drug was stopped
integer
C0304229 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Experimental drug; Discontinuation (procedure); Indication of (contextual qualifier)
Code List
If study drug stopped, check the primary reason drug was stopped
CL Item
Adverse Experience (record details on ADVERSEnEXPERIENCES pages) (1)
CL Item
Death (Check only, if death is NOT an outcome of an adverse experience) (2)
CL Item
Inadequate response to study drug (including seizure exacerbation) (3)
CL Item
Consent withdrawn (4)
CL Item
Lost to follow-up (5)
CL Item
Protocol violation (non- compliance or pregnancy) (6)
Date last dose
Item
Date of last dose
date
C1762893 (UMLS CUI [1])
Item Group
End of study record
C0008976 (UMLS CUI-1)
C0444496 (UMLS CUI-2)
Baseline; Complete | Screening procedure; Complete | treatment phases; Complete | Tapering - action; Complete
Item
Did the patient complete the Screen, Baseline, Treatment Phases and Taper?
boolean
C1442488 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0220908 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C0815181 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C0441640 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
Item
If patient did not complete Screen, Baseline, Treatment Phases and Taper, check primary reason.
integer
C1442488 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C0220908 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C0566251 (UMLS CUI [2,3])
C0815181 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C0566251 (UMLS CUI [3,3])
C0441640 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
C0566251 (UMLS CUI [4,3])
undefined item
Code List
If patient did not complete Screen, Baseline, Treatment Phases and Taper, check primary reason.
CL Item
Adverse Experience (record details on ADVERSEnEXPERIENCES pages) (1)
CL Item
Death (Check only, if death is NOT an outcome of an adverse experience) (2)
CL Item
Inadequate response to study drug (including seizure exacerbation) (3)
CL Item
Consent withdrawn (4)
CL Item
Lost to follow-up (5)
CL Item
Protocol violation (non- compliance or pregnancy) (6)
Discharge date; Study
Item
Date patient discharged from the study
date
C2361123 (UMLS CUI [1,1])
C2603343 (UMLS CUI [1,2])
Cessation of life; Clinical Trials; During
Item
Did the patient die anytime during the study (Baseline Day 1 through Taper and Folllow-Up Phases?)
boolean
C0011065 (UMLS CUI [1,1])
C0008976 (UMLS CUI [1,2])
C0347984 (UMLS CUI [1,3])
C1442488 (UMLS CUI [2])
C0441640 (UMLS CUI [3])
C1522577 (UMLS CUI [4])
Death Related to Adverse Event; Date of onset
Item
If patient died, onset date of the event wich led to death
date
C1705232 (UMLS CUI [1,1])
C0574845 (UMLS CUI [1,2])
Date of death
Item
Date of death
date
C1148348 (UMLS CUI [1])
Item
Characterize the cause of death
integer
C0007465 (UMLS CUI [1])
Cause of Death
Code List
Characterize the cause of death
CL Item
Accidental (1)
CL Item
Seizure- related (If seizure- related, check one) (2)
CL Item
Aspiration (3)
CL Item
Status epilepticus (4)
CL Item
Drowning (5)
CL Item
Other (specify) (6)
Cause of Death; Other; Specification
Item
If other cause of death, specify.
text
C0007465 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,3])
Item
Check attribution of death to study medication
integer
C0011065 (UMLS CUI [1,1])
C0304229 (UMLS CUI [1,2])
C0596130 (UMLS CUI [1,3])
undefined item
Code List
Check attribution of death to study medication
CL Item
Not a reasonable possibility (1)
CL Item
A resonable possibility (2)
Autopsy
Item
Was an autopsy performed?
boolean
C0004398 (UMLS CUI [1])
Item Group
Status of randomization code/ Investigator's statement
C0034656 (UMLS CUI-1)
C0805701 (UMLS CUI-2)
C0449438 (UMLS CUI-3)
C0008961 (UMLS CUI-4)
C1710187 (UMLS CUI-5)
Randomization; Code; Blinded Clinical Study Unit
Item
Was the blind on the randomization code for this patient broken?
boolean
C0034656 (UMLS CUI [1,1])
C0805701 (UMLS CUI [1,2])
C2347038 (UMLS CUI [1,3])
C3846158 (UMLS CUI [1,4])
Date in time; Blinded Clinical Study
Item
Date of blind was broken
date
C0011008 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
C3846158 (UMLS CUI [1,3])
Date in time; Blinded Clinical Study
Item
Reason for breaking blind
text
C0011008 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
C3846158 (UMLS CUI [1,3])
Item Group
Investigator's statement
C0008961 (UMLS CUI-1)
C1710187 (UMLS CUI-2)
Investigator Signature
Item
Investigator's Signature
text
C2346576 (UMLS CUI [1])
Investigator Signature; Date in time
Item
Date of Signature
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Investigator Name
Item
Investigator's name
text
C2826892 (UMLS CUI [1])
Item Group
Laboratory Comments - Unscheduled Laboratory Assessment
C0022877 (UMLS CUI-1)
C0947611 (UMLS CUI-2)
C0220825 (UMLS CUI-3)
C0022877 (UMLS CUI-4)
C3854240 (UMLS CUI-5)
Laboratory Results; Clinical Significance; Unexpected
Item
Do you consider any of the laboratory values at this clinic visit to be of potential OR actual clinical significance AND unexpected in this patient population?
boolean
C1254595 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C4055646 (UMLS CUI [1,3])
Item Group
Laboratory results that are of potential or actual clinical significance and unexpected
C1254595 (UMLS CUI-1)
C2826293 (UMLS CUI-2)
C4055646 (UMLS CUI-3)
Laboratory; Parameter Value
Item
Laboratory parameter
text
C0022877 (UMLS CUI [1,1])
C0549193 (UMLS CUI [1,2])
Comment | Laboratory; Parameter Value
Item
Comment (Laboratory parameter)
text
C0947611 (UMLS CUI [1])
C0022877 (UMLS CUI [2,1])
C0549193 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial